AU679905B2 - Moulded bodies, in particular pellets, containing one or more plant extracts, and the pharmaceutical or cosmetic use of such pellets - Google Patents

Moulded bodies, in particular pellets, containing one or more plant extracts, and the pharmaceutical or cosmetic use of such pellets

Info

Publication number
AU679905B2
AU679905B2 AU33431/93A AU3343193A AU679905B2 AU 679905 B2 AU679905 B2 AU 679905B2 AU 33431/93 A AU33431/93 A AU 33431/93A AU 3343193 A AU3343193 A AU 3343193A AU 679905 B2 AU679905 B2 AU 679905B2
Authority
AU
Australia
Prior art keywords
pellets
plant
plant extracts
forming agent
gelatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU33431/93A
Other versions
AU3343193A (en
Inventor
Jurgen Freidenreich
Ursula Schick
Jurgen Werry
Jens-Christian Wunderlich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfatec Pharma GmbH
Original Assignee
Alfatec Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4201179A external-priority patent/DE4201179A1/en
Priority claimed from DE4201172A external-priority patent/DE4201172C1/en
Application filed by Alfatec Pharma GmbH filed Critical Alfatec Pharma GmbH
Publication of AU3343193A publication Critical patent/AU3343193A/en
Application granted granted Critical
Publication of AU679905B2 publication Critical patent/AU679905B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A61K8/0225—Granulated powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings

Abstract

Described are moulded bodies, in particular pellets, containing one or more plant extracts and made from a dispersion of one or more plant extracts in a matrix consisting mainly of a structure-forming agent, i.e. collagen, gelatin, fractionated gelatin, a collagen hydrolysate, a gelatin derivative, a plant protein or a plant-protein hydrolysate. Such pellets have a long storage life and their pharmacological and cosmetic properties are essentially the same as those of the natural extract. They are prepared by a simple method in which one or more liquid plant extracts are mixed or emulsified, or solid extracts dissolved or suspended, in a solution of the structure-forming agent, the dispersion of structure-forming agent and plant extract(s) is added dropwise to an inert low-temperature liquified gas, preferably liquid nitrogen, thus forming the pellets, and the pellets thus formed are dried. The preferred plant extract is Aloe vera juice.
AU33431/93A 1992-01-17 1993-01-18 Moulded bodies, in particular pellets, containing one or more plant extracts, and the pharmaceutical or cosmetic use of such pellets Ceased AU679905B2 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
DE4201179 1992-01-17
DE4201172 1992-01-17
DE4201179A DE4201179A1 (en) 1992-01-17 1992-01-17 Granulates or pellets comprising dispersion of active agent in hydrophilic macromolecules - are e.g. for treatment of depression, hypertension, rheumatism, etc.
DE4201172A DE4201172C1 (en) 1992-01-17 1992-01-17 Pellets contg. Aloe vera extract - useful, e.g. as antiinflammatory of antibiotic agents, or for treating gastric ulcers
US07/876,876 US5387415A (en) 1992-01-17 1992-04-30 Aloe vera juice containing pellets process for production thereof and the use thereof as pharmaceutical, cosmetic and peroral agents
US876876 1992-04-30
US07/876,866 US5401502A (en) 1992-01-17 1992-04-30 Pellets containing plant extracts, process of making same and their pharmaceutical peroral or cosmetic use
US876866 1992-04-30
PCT/DE1993/000037 WO1993013754A1 (en) 1992-01-17 1993-01-18 Moulded bodies, in particular pellets, containing one or more plant extracts, and the pharmaceutical or cosmetic use of such pellets

Publications (2)

Publication Number Publication Date
AU3343193A AU3343193A (en) 1993-08-03
AU679905B2 true AU679905B2 (en) 1997-07-17

Family

ID=27435368

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33431/93A Ceased AU679905B2 (en) 1992-01-17 1993-01-18 Moulded bodies, in particular pellets, containing one or more plant extracts, and the pharmaceutical or cosmetic use of such pellets

Country Status (10)

Country Link
EP (1) EP0620727B1 (en)
JP (1) JPH07502735A (en)
AT (1) ATE151631T1 (en)
AU (1) AU679905B2 (en)
CA (1) CA2128242C (en)
DE (1) DE59306197D1 (en)
DK (1) DK0620727T3 (en)
ES (1) ES2102637T3 (en)
GR (1) GR3024062T3 (en)
WO (1) WO1993013754A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0701815T3 (en) 1992-01-17 2000-02-07 Alfatec Pharma Gmbh Process for the preparation of active ingredient powders, granules or pellets with a basic structure of hydrophilic macar
DE19603019C2 (en) * 1996-01-17 1998-10-15 Lancaster Group Gmbh Cosmetic skin cleanser based on natural ingredients
IL131317A (en) * 1999-08-09 2006-08-01 Cts Chemical Ind Ltd Binder for pharmaceutical compositions
JP2003160440A (en) * 2001-11-26 2003-06-03 Mikimoto Pharmaceut Co Ltd Nacreous layer powder
WO2004035023A1 (en) * 2002-10-16 2004-04-29 Dr. Suwelack Skin & Health Care Ag Use of molded bodies for external application
CA2789993C (en) 2003-04-11 2016-02-16 Cargill, Incorporated Pellet systems for preparing beverages
CA2730998C (en) * 2008-07-18 2016-08-23 Vincent M. Cavallini Frozen pellets made with juice
EP4230187A1 (en) * 2022-02-21 2023-08-23 Biofactoria Naturae Et Salus Sa Single-dose cosmetic product and process of manufacturing thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1397583A (en) * 1964-05-04 1965-04-30 Hoffmann La Roche Process for the preparation of compositions containing substances sensitive to oxidation
AU646428B2 (en) * 1989-12-22 1994-02-24 Janssen Pharmaceutica Inc. Preparation of pharmaceutical and other matrix systems by solid-state dissolution

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE454386C (en) * 1924-05-27 1928-01-06 Chemische Produkte Vormals H S Process for the production of pharmaceutical and dietetic preparations in spherical form
GB242323A (en) * 1924-07-04 1925-11-04 Firm Knoll & Co Chem Fab An improved method of manufacturing medicinal jujubes
GB887901A (en) * 1960-04-13 1900-01-01
BE770604A (en) * 1971-07-28 1971-12-01 Hoffmann La Roche High potency vitamin e powders

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1397583A (en) * 1964-05-04 1965-04-30 Hoffmann La Roche Process for the preparation of compositions containing substances sensitive to oxidation
AU646428B2 (en) * 1989-12-22 1994-02-24 Janssen Pharmaceutica Inc. Preparation of pharmaceutical and other matrix systems by solid-state dissolution

Also Published As

Publication number Publication date
GR3024062T3 (en) 1997-10-31
ATE151631T1 (en) 1997-05-15
DE59306197D1 (en) 1997-05-22
ES2102637T3 (en) 1997-08-01
EP0620727A1 (en) 1994-10-26
DK0620727T3 (en) 1997-05-26
WO1993013754A1 (en) 1993-07-22
EP0620727B1 (en) 1997-04-16
CA2128242C (en) 1998-09-22
AU3343193A (en) 1993-08-03
JPH07502735A (en) 1995-03-23
CA2128242A1 (en) 1993-07-22

Similar Documents

Publication Publication Date Title
DK0506884T3 (en) Method of delivering molecules to eukaryotic cells
ATE257407T1 (en) PRODUCTION OF BIODEGRADABLE MICROBEADS CONTAINING PEPTIDES BY A MELTING PROCESS
DE69032424D1 (en) OSTEOGENIC DEVICES
FR2619314B1 (en) FACTOR VIII ANALOG, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
ES2039929T3 (en) PROCEDURE FOR THE PREPARATION OF LIPOSOMES AND / OR BIOLOGICAL CELLS CONTAINING CONSTITUTIVE SUBSTANCES, AS WELL AS THEIR APPLICATION.
NO973848L (en) Process for the preparation of hemoglobin-like protein
NO174274C (en) Pigment additives for animal premixtures, methods of preparation and use thereof
AU679905B2 (en) Moulded bodies, in particular pellets, containing one or more plant extracts, and the pharmaceutical or cosmetic use of such pellets
DE69407404D1 (en) SOLID PREPARATION WITH HIGH RELEASE, THEIR PRODUCTION AND USE
IL85929A0 (en) Compact polymer/metal particles,aqueous dispersions thereof,process for preparation thereof and applications thereof
DE59307073D1 (en) PELLETS CONTAINING PEPTIC DRUGS AND THEIR PRODUCTION AND USE THEREOF
GR3030675T3 (en) Process for producing powders, granulates or pellets containing active substances and a structure consisting of hydrophilic macromolecules, and use thereof
DE68909958D1 (en) Phenoxyacetic acid derivatives, their preparation, pharmaceutical compositions containing them and their use.
ATE6032T1 (en) BIOLOGICALLY ACTIVE SUBSTANCES, THEIR PRODUCTION FROM HUMAN CASEIN AND PREPARATIONS CONTAINING THEM.
Jeng et al. Purification and characterization of reversible sperm motility inhibitors from porcine seminal plasma
PH27214A (en) N-2,3-butadienyl tri and tetraaminoalkane derivatives
AU3744889A (en) Variants of plasminogen activators and processes for their production
IL93988A0 (en) Substituted 1,8-naphthyridines,their preparation and medicaments comprising them
Andrews et al. Distribution and binding of glycosaminoglycan polysulfate to intervertebral disc, knee joint articular cartilage and meniscus
ATE405291T1 (en) AGENT FOR INFLUENCING HYPERACTIVATED IMMUNOLOGICAL EFFECTOR CELLS
CA2051260A1 (en) Anti-oxidant system based on a basic amino acid associated with at least one tocopherol or one of its derivatives and at least one non-thiolated polypeptide, and compositions containing such an anti-oxidant system
ATE211502T1 (en) NOVEL PLANT EXTRACTS, PRODUCTION METHOD FOR THE SAME AND USE IN COSMETICS
EA199800918A1 (en) SIGNALS DESIGNED FROM THE OWNER FOR INDUCING THE EXPRESSION OF THE ISOPRENOID GENE AND THEIR APPLICATION
ATE115565T1 (en) 2-HALOGENE SUBSTITUTED N-INDOLYLETHYL SULFONIC AMIDES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE IN PHARMACEUTICALS.
Ruda et al. Colocalization of opioid peptide and fos protein in a rat model of peripheral inflammation and hyperalgesia